FDA meets with Guidant to discuss heart device defect

05/25/2005 | NYTimes.com

The Food and Drug Administration yesterday met with Guidant to discuss the company's disclosure this week that it failed to disclose a design flaw in an implantable defibrillator and did not reveal that the manufacturing process was changed in 2002 to fix it. Company officials said they followed FDA guidelines in reporting problems about the device to the agency.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA